AQR Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Sell |
|
|||||
|
2025
Q1 | $1.77M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $73.2K | Sell |
|
|||||
|
2023
Q3 | $182K | Buy |
|
|||||
|
2023
Q2 | $237K | Buy |
|
|||||
|
2023
Q1 | $139K | Sell |
|
|||||
|
2022
Q4 | $792K | Buy |
|
|||||
|
2022
Q3 | $611K | Buy |
|
|||||
|
2022
Q2 | $108K | Buy |
|
|||||
|
2022
Q1 | $51K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $116K | Hold |
|
|||||
|
2021
Q2 | $167K | Sell |
|
|||||
|
2021
Q1 | $751K | Buy |
|
|||||
|
2020
Q4 | $1.08M | Sell |
|
|||||
|
2020
Q3 | $869K | Sell |
|
|||||
|
2020
Q2 | $1.24M | Buy |
|
|||||
|
2020
Q1 | $118K | Buy |
|